Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30069339HIVENSG00000104375.17protein_codingSTK3NoNo6788A0A087WZ06
Q13188
TVIS30069340HIVENSG00000104375.17protein_codingSTK3NoNo6788A0A087WZ06
Q13188
TVIS30069341HIVENSG00000104375.17protein_codingSTK3NoNo6788A0A087WZ06
Q13188
TVIS30069342HIVENSG00000104375.17protein_codingSTK3NoNo6788A0A087WZ06
Q13188
TVIS30069343HIVENSG00000104375.17protein_codingSTK3NoNo6788A0A087WZ06
Q13188
TVIS30069344HIVENSG00000104375.17protein_codingSTK3NoNo6788A0A087WZ06
Q13188
TVIS30069345HIVENSG00000104375.17protein_codingSTK3NoNo6788A0A087WZ06
Q13188
TVIS30069346HIVENSG00000104375.17protein_codingSTK3NoNo6788A0A087WZ06
Q13188
TVIS30069347HIVENSG00000104375.17protein_codingSTK3NoNo6788A0A087WZ06
Q13188
TVIS30069348HIVENSG00000104375.17protein_codingSTK3NoNo6788A0A087WZ06
Q13188
TCGA Plot Options
Drug Information
GeneSTK3
DrugBank IDDB12010
Drug NameFostamatinib
Target IDBE0009384
UniProt IDQ13188
Regulation Typeinhibitor
PubMed IDs26516587
CitationsRolf MG, Curwen JO, Veldman-Jones M, Eberlein C, Wang J, Harmer A, Hellawell CJ, Braddock M: In vitro pharmacological profiling of R406 identifies molecular targets underlying the clinical effects of fostamatinib. Pharmacol Res Perspect. 2015 Oct;3(5):e00175. doi: 10.1002/prp2.175. Epub 2015 Sep 4.
GroupsApproved; Investigational
Direct ClassificationMethoxyanilines
SMILESCOC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Pathways
PharmGKB
ChEMBLCHEMBL2103830